|
|
Form S-1
|
|
|
|
(Form Type)
|
|
|
|
CHEMOMAB THERAPEUTICS LTD.
|
|
|
|
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
Security
Type |
|
Security
Class Title |
|
Fee
Calculation or Carry Forward Rule |
|
Maximum
Aggregate Offering Price(1)(2) |
|
|
Fee
Rate |
|
Amount of
Registration Fee |
|
|||
|
Newly Registered Securities
|
|
||||||||||||||||
|
Fees to be Paid
|
|
Equity
|
|
American Depositary Shares (2)
|
|
(1)
|
|
$
|
15,000,000.00
|
|
|
$
|
.0001102
|
|
$
|
1,653.00
|
|
|
Fees to be Paid
|
|
Other
|
|
Warrants to Purchase American Depositary Shares (2)
|
|
(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
Fees to be Paid
|
|
Equity
|
|
American Depositary Shares issuable upon exercise of warrants (2)
|
|
(1)
|
|
$
|
15,000,000.00
|
|
|
$
|
.0001102
|
|
$
|
1,653.00
|
|
|
|
|
Total Offering Amounts
|
|
|
$
|
30,000,000.00
|
|
|
|
|
|
$
|
3,306.00
|
|
|||
|
|
|
Total Fees Previously Paid
|
|
|
|
|
|
|
|
|
|
$
|
2,534.60
|
|
|||
|
|
|
Total Fee Offsets
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|||
|
|
|
Net Fee Due
|
|
|
|
|
|
|
|
|
|
$
|
771.40
|
|
|||
|
|
(1)
|
Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the
Securities Act of 1933, as amended.
|
|
|
|
|
|
|
(2)
|
Each ADS represents twenty (20) ordinary shares of the registrant. ADSs issuable upon deposit of the ordinary shares
registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-229522).
|
|
|
|
|
|
|
(3)
|
Calculated in accordance with Rule 457(g) under the Securities Act, because the ADSs of the registrant underlying the
warrants are registered hereby.
|